药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Levorphanol
Cicletanine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Cicletanine.
Levorphanol
Pilsicainide
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Pilsicainide.
Levorphanol
Givinostat
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Givinostat.
Levorphanol
Temefos
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Temefos.
Levorphanol
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Prulifloxacin.
Levorphanol
CUDC-907
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with CUDC-907.
Levorphanol
Anisodamine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Anisodamine.
Levorphanol
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Pazufloxacin.
Levorphanol
Bilastine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Bilastine.
Levorphanol
Difloxacin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Difloxacin.
Levorphanol
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Sarafloxacin.
Levorphanol
Phosmet
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Phosmet.
Levorphanol
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Orbifloxacin.
Levorphanol
Fenthion
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Fenthion.
Levorphanol
Famphur
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Famphur.
Levorphanol
Dichlorvos
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Dichlorvos.
Levorphanol
Coumaphos
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Coumaphos.
Levorphanol
Acrivastine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Acrivastine.
Levorphanol
Flumequine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Flumequine.
Levorphanol
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Chlorcyclizine.